Epoprostenol Sodium is a synthetic analogue of prostacyclin classified as a potent vasodilator used to treat primary pulmonary hypertension and pulmonary hypertension by relaxing vascular smooth muscle… Read more



![Chemical structure of Sodium (Z)-5-((3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxyoct-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-ylidene)pentanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FSodium-Z-5-3aR4R5R6aS-5-hydroxy-4-SE-3-hydroxyoct-1-en-1-ylhexahydro-2H-cyclopentabfuran-2-ylidenepentanoate.png&w=3840&q=75)

Epoprostenol Sodium is a synthetic analogue of prostacyclin classified as a potent vasodilator used to treat primary pulmonary hypertension and pulmonary hypertension by relaxing vascular smooth muscle and inhibiting platelet aggregation. As a pharmaceutical compound requiring rigorous quality standards, laboratories rely on high-quality analytical tools to ensure therapeutic efficacy and safety. This category contains essential reference standards for the active pharmaceutical ingredient, alongside its known pharmacopeial and non-pharmacopeial impurities, such as related compound B. Furthermore, researchers use these materials for critical applications including impurity profiling, method validation, and routine quality control testing. To support accurate quantification and identification in complex matrices, stable isotope labelled compounds are also provided. By utilizing these precise reference materials, analytical chemists can reliably perform assay development and maintain compliance with regulatory standards throughout the drug development and manufacturing lifecycle.